Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/23786503
Conclusion of this study
No major side effect was encountered by any patient. Skin type is a significant factor in choosing between topical nicotinamide and clindamycin in patients with acne vulgaris.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study